medigraphic.com
SPANISH

Medicina & Laboratorio

ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Medicina & Laboratorio 2020; 24 (4)

Placental chorioangioma: case report in the Pathology Unit of the San Juan de Dios E.S.E. Hospital in Rionegro-Antioquia

Torres-Correa JE, Sánchez-Montoya MA, Sandoval-Sánchez J, Castro-Álvarez JF
Full text How to cite this article

Language: Spanish
References: 23
Page: 325-332
PDF size: 1215.05 Kb.


Key words:

hemangioma, immunohistochemistry, trophoblastic neoplasms, pregnancy, fetal death.

ABSTRACT

Among vascular gestational nontrophoblastic tumors, chorioangioma is the most common. It is characterized by an exaggerated proliferation of vascular structures, with endothelial cells and chorionic villi that generate abnormalities of both arterial and venous blood vessels. It has an incidence of less than 1%, with perinatal mortality rates between 18% to 40%. We present the case of a 21-year-old patient without previous prenatal controls, with a placental chorioangioma diagnosed at 26 weeks of gestation that formed a 7 cm accessory lobe, with positive staining during immunohistochemical analysis for smooth anti-muscle antibodies and CD34, and negative for Ki67. The placental chorioangioma triggered complications during pregnancy, with preterm delivery, hydrops fetalis, and intrauterine growth retardation leading to fetal death. The lack of prenatal control in our patient prevented an early detection of placental abnormalities with a fatal outcome for the fetus. Adequate prenatal control with ultrasound monitoring can avoid fatal events such as the one presented. Macroscopic and microscopic analysis of the placenta can help identify cases and contribute to incidence and mortality statistics.


REFERENCES

  1. Clarke J, Banks J. Account of a tumour found in the substance of the human placenta. Philos Trans Royal Soc 1798;88:361-368.

  2. Fan M, Skupski DW. Placental chorioangioma: literature review. J Perinat Med 2014;42:273- 279. https://doi.org/10.1515/jpm-2013-0170.

  3. Lim FY, Coleman A, Polzin W, Jaekle R, Habli M, Van Hook J, et al. Giant chorioangiomas: perinatal outcomes and techniques in fetoscopic devascularization. Fetal Diagn Ther 2015;37:18-23. https://doi. org/10.1159/000363600.

  4. Guschmann M, Henrich W, Entezami M, Dudenhausen JW. Chorioangioma: new insights into a well-known problem. I. Results of a clinical and morphological study of 136 cases. J Perinat Med 2003;31:163-169. https://doi. org/10.1515/jpm.2003.022.

  5. Wu Z, Hu W. Clinical analysis of 26 patients with histologically proven placental chorioangiomas. Eur J Obstet Gynecol Reprod Biol 2016;199:156-163. https://doi.org/10.1016/j. ejogrb.2015.12.009.

  6. Buca D, Iacovella C, Khalil A, Rizzo G, Sirotkina M, Makatsariya A, et al. Perinatal outcome of pregnancies complicated by placental chorioangioma: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2020;55:441- 449. https://doi.org/10.1002/uog.20304.

  7. Zanardini C, Papageorghiou A, Bhide A, Thilaganathan B. Giant placental chorioangioma: natural history and pregnancy outcome. Ultrasound Obstet Gynecol 2010;35:332-336. https://doi.org/10.1002/uog.7451.

  8. Liu H, Gu W, Li X. Natural history and pregnancy outcome in patients with placental chorioangioma. J Clin Ultrasound 2014;42:74-80. https://doi.org/10.1002/jcu.22101.

  9. Guschmann M, Henrich W, Dudenhausen JW. Chorioangiomas: new insights into a well-known problem. II. An immuno-histochemical investigation of 136 cases. J Perinat Med 2003;31:170- 175. https://doi.org/10.1515/jpm.2003.023.

  10. Pérez GG, Sierra AJ, Rangel NE, Fuentes PJ. Corangioma placentario: enfoque clínico-patológico de un caso descrito en Colombia. Ginecol Obstet Mex 2013;81:109-114.

  11. Sarmiento-Rodríguez A, Quijano-García FE, Puccini-Santamaría G, Rodríguez-Acosta N, Victoria-Gómez PA. Corioangioma placentario: Reporte de caso y revisión de la literatura. Rev Colomb Obstet Ginecol 2008;59:57-61.

  12. Acosta-Cajiao E, Acosta-Lleras E, Amaya L, Navas G. Corioangioma diagnóstico anteparto e implicaciones fisiopatológicas. Rev Colomb Obstet Ginecol 1990;41:233-237. https://doi. org/10.18597/rcog.973.

  13. Ramírez-Cárdenas A, Licona-Venegas EE, Licona- Meníndez RD. Corioangioma placentario gigante. Reporte de un caso. Ginecol Obstet Mex 2018;86:692-698.

  14. Kurjak A, Chervenak FA. Ecografía en Obstetricia y Ginecologia. 2da ed. Buenos Aires, Argentina: Editorial Médica Panamericana S.A.; 2009. p. 1010. ISBN 9789500609135.

  15. Abdalla N, Piórkowski R, Stanirowski P, Pazura M, Cendrowski K, Sawicki W. Can ultrasound be helpful in selecting optimal management methods for pregnancies complicated by placental non-trophpblastic tumors? J Ultrason 2017;17:116-122. https://doi.org/10.15557/ JoU.2017.0017.

  16. Domingo ID, Coronado Martin P, Badillo CA, Rincón J, Montalvo J, Cristobal I, et al. Placental chorangioma: Prenatal ultrasound diagnostic. Tokoginecol Pract 2001;60:272-275.

  17. Gonzalo I, Martínez-Guisasola J, Martín MA, Rozada P, Klabili M, Fernández G. Corioangioma placentario gigante. Diag Pren 2011;22:136-138. https://doi.org/10.1016/j.diapre. 2011.11.002.

  18. Sirotkina M, Douroudis K, Westgren M, Papadogiannakis N. Association of chorangiomas to hypoxia-related placental changes in singleton and multiple pregnancy placentas. Placenta 2016;39:154-159. https://doi.org/10.1016/j.placenta. 2016.01.020.

  19. Ogino S, Redline RW. Villous capillary lesions of the placenta: distinctions between chorangioma, chorangiomatosis, and chorangiosis. Hum Pathol 2000;31:945-954. https://doi.org/10.1053/ hupa.2000.9036.

  20. Stuar LN. CD markers, CD34. Michigan, USA: PathologyOutlines.com; 2019. Acceso 21 de noviembre de 2019. Disponible en http:// www.pathologyoutlines.com/topic/cdmarkerscd34. html.

  21. Roychowdhury M. Stains Ki67/MIB1. Michigan, USA: PathologyOutlines.com; 2019. Acceso 10 de noviembre de 2019. Disponible en http://www. pathologyoutlines.com/topic/stainski67.html.

  22. Pernick N. Stains, beta-catenin. Michigan, USA: PathologyOutlines.com; 2018. Acceso 12 de noviembre de 2019. Disponible en https:// www.pathologyoutlines.com/topic/stainsbetacatenin. html.

  23. Johnson G. Stains, actin alpha smooth muscle type. Michigan, USA: PathologyOutlines.com; 2018. Acceso 18 de noviembre de 2019. Disponible en http://www.pathologyoutlines.com/topic/ stainsalphasmoothmuscleactin.html.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Medicina & Laboratorio. 2020;24